Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets

Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets

Bibliographic Details
Main Author:	Rhonda F. Souza, MD
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	Cellular and Molecular Gastroenterology and Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352345X18300274

Similar Items

siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell GrowthSummary
by: Shane P. Duggan, et al.
Published: (2018-01-01)

Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
by: Elisa Baldelli, et al.
Published: (2021-09-01)

To Find Regulators of Telomere Maintenance Pathway and a Druggable Target
by: Meng-Hsun Hsieh, et al.
Published: (2017)

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
by: Nakaoku, Takashi
Published: (2016)

Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma
by: Farzaneh Kordbacheh, et al.
Published: (2021-07-01)

p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma
by: Ling Yang, et al.
Published: (2019-11-01)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
by: Syed S. Hassan, et al.
Published: (2018-02-01)

Mitochondrial Potassium Channels as Druggable Targets
by: Antoni Wrzosek, et al.
Published: (2020-08-01)

Tyrosine Kinases as Druggable Targets in Cancer
Published: (2019)

Identification of specific metabolic pathways as druggable targets regulating the sensitivity to cyanide poisoning.
by: Patrick Y Sips, et al.
Published: (2018-01-01)

Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways.
by: Jing Tang, et al.
Published: (2013-01-01)

Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness
by: Nora Pencheva, et al.
Published: (2017-07-01)

Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability
by: Marina Pierrevelcin, et al.
Published: (2020-08-01)

Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma developmentResearch in context
by: Tianshun Zhang, et al.
Published: (2019-11-01)

Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors
by: Wagner Ricardo Montor, et al.
Published: (2018-02-01)

Immune determinants of Barrett’s progression to esophageal adenocarcinoma
by: Kiran H. Lagisetty, et al.
Published: (2021-01-01)

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia
by: Stefania Rocca, et al.
Published: (2018-02-01)

The Future Prospects of Immune Therapy in Gastric and Esophageal Adenocarcinoma
by: Walid L. Shaib, et al.
Published: (2016-11-01)

Esophageal Adenocarcinoma: Opportunities for Targeted Prevention in Ohio
by: Julie A Stephens, et al.
Published: (2018-07-01)

Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target
by: Sergio Enríquez-Flores, et al.
Published: (2020-07-01)

New Insights Into DNA Helicases as Druggable Targets for Cancer Therapy
by: Arindam Datta, et al.
Published: (2018-06-01)

Basigin is a druggable target for host-oriented antimalarial interventions
by: Zenonos, Zenon A., et al.
Published: (2016)

Finding potential drug targets against Shigella flexneri through druggable proteome exploration.
by: Mohammad Uzzal Hossain, et al.
Published: (2016-11-01)

Druggable Targets in Cyclic Nucleotide Signaling Pathways in Apicomplexan Parasites and Kinetoplastids against Disabling Protozoan Diseases in Humans
by: Annette Kaiser
Published: (2019-01-01)

Unbiased discovery of druggable genomic targets by Click-sequencing (Click-seq)
by: Zacharioudakis, Emmanouil
Published: (2015)

Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins
by: Sina Ghadermarzi, et al.
Published: (2019-11-01)

Verification of EZH2 as a druggable target in metastatic uveal melanoma
by: Bei Jin, et al.
Published: (2020-03-01)

IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants
by: Andrea Saggini, et al.
Published: (2014-01-01)

Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
by: Seul-Ki Choi, et al.
Published: (2019-08-01)

Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
by: Hong Kyu Lee, et al.
Published: (2020-10-01)

The Role of Mitochondrial Dysfunction in Atrial Fibrillation: Translation to Druggable Target and Biomarker Discovery
by: Lisa Pool, et al.
Published: (2021-08-01)

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
by: Alba Di Pardo, et al.
Published: (2017-07-01)

Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
by: Shayan Khalafi, et al.
Published: (2020-10-01)

Prevalence of Esophageal Adenocarcinoma
by: Awori Mark, et al.
Published: (2017-07-01)

Prevalence of Esophageal Adenocarcinoma
by: Daniel Ojuka, et al.
Published: (2017-01-01)

COP9 signalosome is an essential and druggable parasite target that regulates protein degradation.
by: Swagata Ghosh, et al.
Published: (2020-09-01)

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia
by: Yujia Zhou, et al.
Published: (2020-12-01)

Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
by: Sara Grassi, et al.
Published: (2019-07-01)

Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling
by: Amnani Aminuddin, et al.
Published: (2016-08-01)

Accelerating the Production of Druggable Targets: Eukaryotic Cell-Free Systems Come into Focus
by: Lena Thoring, et al.
Published: (2019-04-01)